VKTXW
Viking Therapeutics Inc
Halal Rating :
Last Price
$4.50
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Viking Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders. The company's lead product candidates include VK2809 for the treatment of non-alcoholic steatohepatitis (NASH) and VK5211 for patients recovering from hip fracture. The company's research and development efforts are focused on developing innovative treatments for diseases with significant unmet medical needs.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Viking Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.